Email Updates

Search form

You are here

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
3Ps Demonstration Project Demo Project DTHF; University of Washington; funded by NIH/DAIDS South Africa Women Planned
A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP) Open Label Wednesday, September 4, 2013 Gilead Sciences Women, Men Ongoing June 2018
Acceptability of HIV Oral PrEP Among MSM and TGW Open Label Monday, January 4, 2016 Chiang Mai University Men, Transgender Ongoing December 2016
AMPrEP (Amsterdam PrEP) Demo Project Friday, June 12, 2015 Academic Medical Center, PHSA Netherlands Men, Transgender, MSM Ongoing December 2018
Anova Health Institute's Health4Men Initiative Demo Project Wednesday, December 30, 2015 Anova Health Institute, Desmond Tutu HIV Foundation, Elton John AIDS Foundation South Africa, United Republic of Tanzania, Swaziland, Thailand, Uganda, Lesotho MSM Ongoing February 2016
ATN 110 II Friday, November 30, 2012 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) United States of America Men TDF/FTC (Truvada) Completed November 2015
ATN 113 (Project PrEPare) Demo Project, Open Label, II Sunday, March 31, 2013 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) United States of America MSM TDF/FTC (Truvada) Completed March 2016
Bangkok Tenofovir Study (BTS) Follow-Up Open Label Bangkok Metropolitan Administration, CDC, Gilead Thailand Women, Men, Injecting drug users Completed
Be PrEPared - The Antwerp PrEP Project Demo Project Thursday, September 17, 2015 ITM, TBM, IWT Belgium MSM TDF/FTC (Truvada) Ongoing June 2017
Be-PrEP-ared Demo Project Wednesday, September 16, 2015 Belgium MSM

Pages